PRA Group, Inc. logo PRAA - PRA Group, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY 0
BUY 5
HOLD 8
SELL 0
STRONG
SELL 0
| PRICE TARGET: $25.00 DETAILS
HIGH: $26.00
LOW: $24.00
MEDIAN: $25.00
CONSENSUS: $25.00
UPSIDE: 29.85%

Stock News

Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications

Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications

REDWOOD CITY, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. (Nasdaq: BOLT) (“Bolt” or the “Company”) today announced the acquisition of Prana Therapies, Inc. (“Prana”), a clinical-stage biotechnology company pioneering next-generation half-life-extended multispecific antibodies designed to deliver best-in-disease therapies. Following the acquisition, the Company will focus on advancing Prana's pipeline of half-life-extended multispecific antibodies generated from its proprietary INSPIRE platform, led by PRA-216, a novel IL-4Rα/TSLP bispecific antibody currently in Phase 2 development in asthma, chronic obstructive pulmonary disease (COPD) and atopic dermatitis, with a Phase 2 study in eosinophilic esophagitis (EoE) planned.

Oct 23, 2026 05:08 AM • globenewswire.com
PRA Group: Outsized Discount To Book Value Given Resilient Recoveries

PRA Group: Outsized Discount To Book Value Given Resilient Recoveries

PRA Group is rated a 'Buy' after a 22% gain, supported by prudent capital allocation and resilient credit collections, especially in Europe. PRAA's recent $400M debt offering extends maturities to 2033, enhances liquidity, and reduces near-term interest rate risk, with leverage down to 2.7x. Disciplined loan purchasing and improving NPL pricing are increasing expected recoveries, while strong labor markets support ongoing cash collections.

Sep 30, 2026 03:30 AM • seekingalpha.com
PRA Group Announces Pricing of Offering of $400.0 Million of 8.500% Senior Notes due 2033

PRA Group Announces Pricing of Offering of $400.0 Million of 8.500% Senior Notes due 2033

NORFOLK, Va., Sept. 29, 2026 /PRNewswire/ -- PRA Group, Inc. (Nasdaq: PRAA) (the "Company"), a global leader in acquiring and collecting nonperforming loans, announced today the pricing on September 29, 2026 of its offering of $400.0 million aggregate principal amount of 8.500% senior notes due 2033 (the "notes"), in a private transaction that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act").

Sep 29, 2026 01:16 PM • prnewswire.com
PRA Group Announces Proposed Offering of $400.0 Million of Senior Notes due 2033

PRA Group Announces Proposed Offering of $400.0 Million of Senior Notes due 2033

NORFOLK, Va., Sept. 29, 2026 /PRNewswire/ -- PRA Group, Inc. (Nasdaq: PRAA) (the "Company"), a global leader in acquiring and collecting nonperforming loans, announced today that it plans, subject to market and other conditions, to offer $400.0 million aggregate principal amount of senior notes due 2033 (the "notes") in a private transaction that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act").

Sep 29, 2026 04:15 AM • prnewswire.com
PRA Group Highlights Strong NPL Supply, Cost Cuts and $150M Buyback Plan

PRA Group Highlights Strong NPL Supply, Cost Cuts and $150M Buyback Plan

PRA Group (NASDAQ: PRAA) outlined its strategy, operating trends and capital priorities during a company presentation, highlighting a favorable supply environment for non-performing loan portfolios, ongoing cost reductions and investments in technology. Chief Executive Officer Martin Sjolund said the company operates in the market for non-performing loans, purchasing charged-off consumer debt portfolios from banks and finance

Sep 28, 2026 02:02 AM • defenseworld.net

Price Targets